Pantoprazol Kalceks (Pantoprazole)

Pantoprazol Kalceks is a proton pump inhibitor that acts on the acid‑secreting pathway of the stomach. It is indicated for:

• Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis.
• Erosive esophagitis: promotes mucosal healing.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion.
• Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in at‑risk patients.
• Healing of duodenal ulcers: supports ulcer resolution.
• Maintenance therapy for healed erosive esophagitis: helps prevent recurrence.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump in its active state, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Pantoprazol Kalceks may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased intestinal gas.
• Constipation: infrequent bowel changes.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: watery diarrhea, abdominal cramping.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: signs of hepatic stress.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before starting Pantoprazol Kalceks, consider the following safety measures:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review liver health: monitor if hepatic disease is present.
• Evaluate long‑term use: weigh benefits against potential bone fracture risk.
• Monitor electrolytes: especially magnesium during prolonged therapy.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Pantoprazol Kalceks can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

• Ketoconazole and itraconazole: reduced antifungal absorption.
• Atazanavir and nelfinavir: decreased antiviral efficacy.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR values.
• Digoxin: modest increase in serum levels.
• Methotrexate (high dose): reduced clearance leading to toxicity.
• Iron supplements: decreased iron absorption when taken simultaneously.